Overview
PACIV provides single-source engineering services for industrial process automation, instrumentation, control system integration, validation, and regulatory compliance for life sciences manufacturers. It designs, implements, and validates automation systems for batch and continuous manufacturing, and also offers outsourcing to manage a client's day-to-day automation operations. The firm differentiates itself through an integrated, end-to-end service capable of handling projects from design to qualification under one roof, with engineers certified on major platforms and strict adherence to ISA S95/S88 and ISPE GAMP. Its goal is to help pharmaceutical, biotechnology, and medical device companies achieve compliant, efficient, and reliable automation with strong data integrity, enabling clients to focus on core business initiatives.
Work here?Claim your company
Simplify's take
What believers are saying
- PACIV's 2026 career page shows active hiring across the United States and Ireland.
- Blackford expanded PACIV with Ace Controls in January 2025 and DSA, Eight12 earlier.
- PACIV's October 2026 HCAP page still calls it a global life-sciences automation leader.
What critics are saying
- Blackford's 2026 ACG rebrand threatens PACIV identity and employer pull within months.
- Open roles in Indianapolis, Puerto Rico, and Ireland signal persistent delivery-capacity constraints.
- Life-science concentration exposes PACIV to client insourcing shifts and sterile-manufacturing project delays.
What makes PACIV unique
- PACIV bundles automation, validation, and compliance for regulated life sciences under one roof.
- PACIV serves AbbVie, Amgen, Eli Lilly, J&J, Merck, and Pfizer.
- PACIV's outsourcing model runs clients' automation departments, not just one-off projects.
Help us improve and share your feedback! Did you find this helpful?